Translating Pharmacogenetics to Clinical Practice: Do Cytochrome P450 2D6 Ultrarapid Metabolizers Need Higher Atomoxetine Doses?

Jose De Leon

doi:10.1016/j.jaac.2015.04.003

Translating Pharmacogenetics to Clinical Practice: Do Cytochrome P450 2D6 Ultrarapid Metabolizers Need Higher Atomoxetine Doses?

Research output: Contribution to journal › Editorial

13 Scopus citations

Original language	English
Article number	1203
Pages (from-to)	532-534
Number of pages	3
Journal	Journal of the American Academy of Child and Adolescent Psychiatry
Volume	54
Issue number	7
DOIs	https://doi.org/10.1016/j.jaac.2015.04.003
State	Published - Jul 1 2015

ASJC Scopus subject areas

Developmental and Educational Psychology
Psychiatry and Mental health

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jaac.2015.04.003

Cite this

@article{3fd5b7efbaa047ae9affc077658cc59d,

title = "Translating Pharmacogenetics to Clinical Practice: Do Cytochrome P450 2D6 Ultrarapid Metabolizers Need Higher Atomoxetine Doses?",

author = "{De Leon}, Jose",

year = "2015",

month = jul,

day = "1",

doi = "10.1016/j.jaac.2015.04.003",

language = "English",

volume = "54",

pages = "532--534",

number = "7",

}

TY - JOUR

T1 - Translating Pharmacogenetics to Clinical Practice

T2 - Do Cytochrome P450 2D6 Ultrarapid Metabolizers Need Higher Atomoxetine Doses?

AU - De Leon, Jose

PY - 2015/7/1

Y1 - 2015/7/1

UR - http://www.scopus.com/inward/record.url?scp=84931059701&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931059701&partnerID=8YFLogxK

U2 - 10.1016/j.jaac.2015.04.003

DO - 10.1016/j.jaac.2015.04.003

M3 - Editorial

C2 - 26088654

AN - SCOPUS:84931059701

SN - 0890-8567

VL - 54

SP - 532

EP - 534

JO - Journal of the American Academy of Child and Adolescent Psychiatry

JF - Journal of the American Academy of Child and Adolescent Psychiatry

IS - 7

M1 - 1203

ER -

Translating Pharmacogenetics to Clinical Practice: Do Cytochrome P450 2D6 Ultrarapid Metabolizers Need Higher Atomoxetine Doses?

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this